Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
Orders proposed by Apple after a judge’s finding that the digital giant and rival Google engaged in anti-competitive conduct would “rob the court’s findings of their detail, their efficacy and their bite”, Epic Games has said.
A community group has lost a legal challenge to a 50-60 km underground pipeline that will connect Santos’ $3.6 billion Narrabri gas project to the Hunter gas pipeline.
An expert will not be asked to determine a potential cross-claim by Downer EDI Rail in a dispute with John Holland over a rollingstock manufacturing facility being constructed in Torbanlea.
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
Facebook owner Meta has argued the Australian Competition and Consumer Commission has “misallocated responsibility” in its three-year-old case over scam cryptocurrency ads on the social media platform.
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea.
Real estate asset manager Dexus has won access to advice given by the lawyers of two shareholders of airport operator APAC over an alleged breach of a shareholder deed.
Chinese car brand LDV is fighting the consumer regulator’s case alleging it misled customers about its vehicles, telling a court that ads showing the vehicles as durable in off-road terrains were not misleading.